ICO
Closing Date:

Seeking Novel RNA Therapeutics for Oncology Indications

A US-based, publicly traded biotechnology company focused in the area of oncology drug development is seeking early-stage nucleic acid therapeutics for cancer treatment. Specifically, our client is interested in RNA-based therapies that have proven efficacy of causing tumor cell death to take advantage of their existing tumor-targeting delivery platform.

Approaches of Interest:

  • All cancers are within scope
  • Open to all RNA modalities (e.g. siRNA, mRNA, antisense oligonucleotides)
  • Open to all mechanisms and pathways that directly lead to the death of ...

Opportunity types being sought:

  • Technology

  • Academic Researcher

  • Centre of Excellence

  • Research Project

  • Spinout Company

To see the full details and submit your response please register now.

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Opportunity types being sought:

  • Technology

  • Academic Researcher

  • Centre of Excellence

  • Research Project

  • Spinout Company

An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.